Pharmaceutical Methods
Publishing Quality Research & Reviews
Pharmaceutical Methods
Publishing Quality Research & Reviews
Author(s): Bhupendra Shrestha, Nihar Ranjan Bhuyan, and Barij Nayan Sinha
Aim: A stability indicating UHPLC method was developed and validated for the determination of Ceftriaxone and Tazobactam in injectable dosage form. Methods: Separation was performed in a Dionex Ultimate 3000 UHPLC system equipped with chromeleon software using Acclaim 120 C18 (250 mm 4.6 mm, 5 mm particle size) column with mobile phase (pH 7.0) containing methanol, potassium dihydrogen phosphate and triethylamine in the ratio of 14:86:0.2 v/v/v with a flow rate of 1.55 mL/min and detection wavelength of 220 nm. Stress studies were performed using HCl, NaOH, H2O2 and UV radiation. Results: The method was found to be linear in the concentration range of 280e480 mg/mL (R2 ¼ 0.997) and 35e60 mg/mL (R2 ¼ 0.997) with the regression equation y ¼ 24060x þ 200 and y ¼ 9880x 9461 for Ceftriaxone and Tazobactam, respectively. The %RSD of 0.56 and 0.62 for intra-day and 1.08 and 1.62 for inter-day precision, respectively for Ceftriaxone and Tazobactam suggest the precision of the method as all these values are less than 2%. It was found from the stress studies that both the drugs are very susceptible to alkaline condition. The method has shown good, consistent recoveries for Ceftriaxone (98.88e101.24%) and Tazobactam (98.42e100.94%) which are close to 100%. Conclusion: The method was found to be accurate, precise, specific, robust, linear and stability indicating for the determination of Ceftriaxone and Tazobactam in injectable dosage form.
Pharmaceutical Methods received 3403 citations as per google scholar report
